UB Paderborn / Katalog / Suche / in CDI

1 – 21 von 21

Sortiert nach

A Shattered Tomb of Scattered People: The Alvastra Dolmen in Light of Stable Isotopes

Current Swedish archaeology, 2011, Vol.19 (1), p.113-141

Fornander, Elin

2011

Volltextzugriff (PDF)

Wild at heart: Approaching Pitted Ware identity, economy and cosmology through stable isotopes in skeletal material from the Neolithic site Korsnäs in Eastern Central Sweden

Journal of anthropological archaeology, 2008-09, Vol.27 (3), p.281-297

2008

Volltextzugriff (PDF)

Same island, different diet: Cultural evolution of food practice on Öland, Sweden, from the Mesolithic to the Roman Period

Journal of anthropological archaeology, 2008-12, Vol.27 (4), p.520-543

2008

Volltextzugriff (PDF)

Svar till Tobias Lindström

Fornvännen, 2020-01, Vol.115 (2), p.109

2020

Volltextzugriff (PDF)

Ancient human genomes suggest three ancestral populations for present-day Europeans

Nature (London), 2014-09, Vol.513 (7518), p.409-413

2014

Volltextzugriff (PDF)

Increasing Mobility at the Neolithic/Bronze Age Transition - sulphur isotope evidence from Öland, Sweden

Internet archaeology, 2014, Vol.37 (37)

2014

Volltextzugriff (PDF)

Dietary diversity and moderate mobility - isotope evidence from Scanian battle axe culture burials

Journal of Nordic archaeological science, 2013

Fornander, Elin

2013

Volltextzugriff (PDF)

The edutainment scan: immersive media and its deployment in museums

Museum management and curatorship (1990), 2024-05, p.1-18

2024

Volltextzugriff (PDF)

Identifying mobility in populations with mixed marine-terrestrial diets: strontium isotope analysis of skeletal material from a passage grave in Resmo, Öland, Sweden

International journal of osteoarchaeology

Volltextzugriff (PDF)

Cell surface binding and uptake of arginine- and lysine-rich penetratin peptides in absence and presence of proteoglycans

Biochimica et biophysica acta, 2012-11, Vol.1818 (11), p.2669-2678

2012

Volltextzugriff (PDF)

Activation of Akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefit

Breast cancer research and treatment, 2013-01, Vol.137 (2), p.397-406

2013

Volltextzugriff (PDF)

ERRα Is a Marker of Tamoxifen Response and Survival in Triple-Negative Breast Cancer

Clinical cancer research, 2016-03, Vol.22 (6), p.1421-1431

2016

Volltextzugriff (PDF)

PTPN2 deficiency along with activation of nuclear Akt predict endocrine resistance in breast cancer

Journal of cancer research and clinical oncology, 2019-03, Vol.145 (3), p.599-607

2019

Volltextzugriff (PDF)

The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patients from the randomised Stockholm tamoxifen trials

Breast cancer research : BCR, 2013-01, Vol.15 (5), p.R96-R96, Article R96

2013

Volltextzugriff (PDF)

The effects of PTPN2 loss on cell signalling and clinical outcome in relation to breast cancer subtype

Journal of cancer research and clinical oncology, 2019-07, Vol.145 (7), p.1845-1856

2019

Volltextzugriff (PDF)

Loss of protein tyrosine phosphatase, non-receptor type 2 is associated with activation of AKT and tamoxifen resistance in breast cancer

Breast cancer research and treatment, 2015-08, Vol.153 (1), p.31-40

2015

Volltextzugriff (PDF)

Clinical potential of the mTOR targets S6K1 and S6K2 in breast cancer

Breast cancer research and treatment, 2011-08, Vol.128 (3), p.713-723

2011

Volltextzugriff (PDF)

S6 kinase signaling: tamoxifen response and prognostic indication in two breast cancer cohorts

Endocrine-related cancer, 2015-06, Vol.22 (3), p.331-343

2015

Volltextzugriff (PDF)

Met and its ligand HGF are associated with clinical outcome in breast cancer

Oncotarget, 2016-06, Vol.7 (24), p.37145-37159

2016

Volltextzugriff (PDF)

Abstract 3295: S6 kinase signaling in prognosis and tamoxifen response in two randomized breast cancer cohorts

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.3295-3295

2014

Volltextzugriff (PDF)

Abstract A3: mTOR signaling and tamoxifen response in postmenopausal breast cancer

Clinical cancer research, 2012-05, Vol.18 (10_Supplement), p.A3-A3

2012

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(21)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Shattered Tomb of Scattered People: The Alvastra Dolmen in Light of Stable Isotopes

Wild at heart: Approaching Pitted Ware identity, economy and cosmology through stable isotopes in skeletal material from the Neolithic site Korsnäs in Eastern Central Sweden

Same island, different diet: Cultural evolution of food practice on Öland, Sweden, from the Mesolithic to the Roman Period

Svar till Tobias Lindström

Ancient human genomes suggest three ancestral populations for present-day Europeans

Increasing Mobility at the Neolithic/Bronze Age Transition - sulphur isotope evidence from Öland, Sweden

Dietary diversity and moderate mobility - isotope evidence from Scanian battle axe culture burials

The edutainment scan: immersive media and its deployment in museums

Identifying mobility in populations with mixed marine-terrestrial diets: strontium isotope analysis of skeletal material from a passage grave in Resmo, Öland, Sweden

Cell surface binding and uptake of arginine- and lysine-rich penetratin peptides in absence and presence of proteoglycans

Activation of Akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefit

ERRα Is a Marker of Tamoxifen Response and Survival in Triple-Negative Breast Cancer

PTPN2 deficiency along with activation of nuclear Akt predict endocrine resistance in breast cancer

The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patients from the randomised Stockholm tamoxifen trials

The effects of PTPN2 loss on cell signalling and clinical outcome in relation to breast cancer subtype

Loss of protein tyrosine phosphatase, non-receptor type 2 is associated with activation of AKT and tamoxifen resistance in breast cancer

Clinical potential of the mTOR targets S6K1 and S6K2 in breast cancer

S6 kinase signaling: tamoxifen response and prognostic indication in two breast cancer cohorts

Met and its ligand HGF are associated with clinical outcome in breast cancer

Abstract 3295: S6 kinase signaling in prognosis and tamoxifen response in two randomized breast cancer cohorts

Abstract A3: mTOR signaling and tamoxifen response in postmenopausal breast cancer

Suchergebnisse filtern